ERLOTERO-100MG

What is ERLOTERO-100MG?

ERLOTERO 100 MG is an oral anti-cancer medication containing Erlotinib 100 mg, a targeted therapy drug. Erlotinib belongs to the class of tyrosine kinase inhibitors (TKIs) that block the epidermal growth factor receptor (EGFR) pathway, slowing the growth and spread of cancer cells.

---

What is the Use of ERLOTERO-100MG?

ERLOTERO 100 MG is primarily prescribed to:

• Treat non-small cell lung cancer (NSCLC) in patients with EGFR mutation-positive tumors.

• Manage pancreatic cancer in combination with certain chemotherapy regimens.

• Serve as a targeted therapy for cancers where EGFR signaling plays a key role.

---

Benefits of ERLOTERO-100MG

• Targeted action: Focuses on cancer cells with abnormal EGFR activity, reducing harm to normal cells.

• Slows disease progression: Helps delay tumor growth and may extend survival.

• Oral convenience: Taken as a tablet, making treatment easier compared to frequent hospital-based chemotherapy.

---

Side Effects of ERLOTERO-100MG

Common side effects:

• Skin rash or acne-like eruptions

• Diarrhea

• Nausea, vomiting, or loss of appetite

• Fatigue or weakness

Serious side effects (seek medical attention):

• Severe liver problems

• Interstitial lung disease (serious breathing difficulties)

• Eye irritation or vision changes

• Severe allergic reactions

---

Important Notes

• Dosage: Typically taken once daily on an empty stomach (at least 1 hour before or 2 hours after meals) as prescribed by your oncologist.

• Monitoring: Regular blood tests and liver function monitoring are necessary during treatment.

• Precaution: Not recommended during pregnancy or breastfeeding unless advised by a doctor.

1. What is ERLOTERO-100MG used for?

It is prescribed to treat EGFR-positive non-small cell lung cancer (NSCLC) and pancreatic cancer (with chemotherapy).

2. What is the active ingredient?

Erlotinib 100 mg, a targeted therapy medicine known as a tyrosine kinase inhibitor (TKI).

3. How does ERLOTERO-100MG work?

It blocks the epidermal growth factor receptor (EGFR), stopping signals that promote cancer cell growth and division.

4. How should I take this medicine?

Swallow one tablet daily on an empty stomach, at least 1 hour before or 2 hours after food, exactly as prescribed.

5. Can ERLOTERO-100MG be taken with other drugs?

Tell your doctor about all medicines and supplements you use—some antibiotics, antifungals, or antacids can reduce its effectiveness.

6. What are the common side effects?

Skin rash, diarrhea, nausea, vomiting, loss of appetite, and fatigue are most common.

7. What serious side effects require immediate care?

Shortness of breath, severe cough, liver-related symptoms (yellow skin/eyes), eye pain, or severe allergic reactions.

8. Is regular monitoring needed?

Yes. Liver function tests, lung assessments, and eye checks are usually recommended.

9. Can I drink alcohol while taking ERLOTERO-100MG?

Alcohol may worsen liver strain and side effects, so it’s best to limit or avoid it.

10. What if I miss a dose?

Take it as soon as possible unless it’s almost time for the next dose. Do not double the dose.

11. Can pregnant or breastfeeding women take it?

Use is not recommended during pregnancy or breastfeeding unless specifically approved by a doctor.

12. How long before results are seen?

Response varies, but tumor control may be seen after several weeks of continuous therapy.

13. Does ERLOTERO-100MG cure cancer?

No. It is designed to control and slow cancer progression, not to provide a permanent cure.

14. Who should avoid this medicine?

People with known allergy to Erlotinib, severe liver or lung disease, or uncontrolled medical conditions without doctor supervision.

15. How should it be stored?

Keep tablets in a cool, dry place away from moisture and sunlight, out of children’s reach.